Metabolism of glucagon by dipeptidyl peptidase IV (CD26)-Reference-Cited by-同舟云学术

Metabolism of glucagon by dipeptidyl peptidase IV (CD26)

Published:2001-01 Issue:3 Volume:96 Page:133-141
ISSN:0167-0115
Container-title:Regulatory Peptides
language:en
Short-container-title:Regulatory Peptides

Author:

Pospisilik John A,Hinke Simon A,Pederson Raymond A,Hoffmann Torsten,Rosche Fred,Schlenzig Dagmar,Glund Konrad,Heiser Ulrich,McIntosh Christopher H.S,Demuth Hans-Ulrich

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Clinical Biochemistry,Endocrinology,Physiology,Biochemistry

Reference49 articles.

1. Glucose counter-regulatory hormones: physiology, pathophysiology, and relevance to clinical hypoglycemia;Cryer,1996

2. Gastric inhibitory polypeptide;Pederson,1994

3. The incretin concept and its relevance to diabetes;Habener;Endocrinol. Metab. Clin. North Am.,1993

4. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV;Kieffer;Endocrinology,1995

5. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1 (7–36) amide, peptide histidine methionine and is responsible for their degradation in human serum;Mentlein;Eur. J. Biochem.,1993

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contribution of amino acids in the Active site of Dipeptidyl Peptidase 4 to the catalytic action of the enzyme;2023-07-17

2. The molecular pharmacology of glucagon agonists in diabetes and obesity;Peptides;2023-07

3. A physiologic increase in brain glucagon action alters the hepatic gluconeogenic/glycogenolytic ratio but not glucagon’s overall effect on glucose production;American Journal of Physiology-Endocrinology and Metabolism;2023-02-01

4. A Non-Perturbative Molecular Grafting Strategy for Stable and Potent Therapeutic Peptide Ligands;ACS Central Science;2021-02-15

5. Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities;European Journal of Pharmacology;2020-07